Atea Pharmaceuticals, Inc.AVIRNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
100.00%
↑ 101% above average
Average (26q)
-7936.47%
Historical baseline
Range
High:1416.31%
Low:-193775.00%
Volatility
-2459.4%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 100.00% |
| Q2 2025 | 29.68% |
| Q1 2025 | -3207.69% |
| Q4 2024 | 99.48% |
| Q3 2024 | -19056.73% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 99.42% |
| Q3 2023 | -11.92% |
| Q2 2023 | 44.27% |
| Q1 2023 | -96.73% |
| Q4 2022 | 0.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | 100.00% |
| Q1 2022 | -122.05% |
| Q4 2021 | 1416.31% |
| Q3 2021 | -149.58% |
| Q2 2021 | -47.76% |
| Q1 2021 | 13.30% |
| Q4 2020 | 355.77% |
| Q3 2020 | -75.38% |
| Q2 2020 | -193775.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |